Mylan NV
MYL
Delayed Nasdaq - 09/22 10:00:00 pm
31.3USD
+0.19%
Prev.31.2400
Open31.2700
High31.4500
Low30.6900
Volume5 203 980
Last news
Financials
Sales 2017 11 990 M
EBIT 2017 3 301 M
R. net 2017 1 397 M
Debt 2017 13 558 M
Rend. 2017 -
P/E ratio 2017 14,15
P/E ratio 2018 9,52
EV / Sales 2017 2,53x
EV / Sales 2018 2,26x
Capitalization 16 786 M
Company
Mylan N.V., is a pharmaceutical company which engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products.It operates through two segments: Generic and Specialty.The Generic pharmaceutical business is conducted...
Sector :
Pharmaceuticals - NEC
Calendar :
2017-11-02 Earnings Release
Trading Rating :
Investor Rating :
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBearishBearish
Resistance33,635,336,7
Spread/Res.-6,8%-11%-15%
Spread/Supp.5,6%5,6%2,5%
Support29,629,630,5